{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Fort Worth",
      "address_1": "4201 Diplomacy Rd",
      "reason_for_recall": "Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.",
      "address_2": "",
      "product_quantity": "5363 tubes",
      "code_info": "Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020",
      "center_classification_date": "20181220",
      "distribution_pattern": "United States, Maldives, Canada, United Arab Emirates, and New Zealand",
      "state": "TX",
      "product_description": "Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.",
      "report_date": "20181226",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "CBI Laboratories, Inc.",
      "recall_number": "D-0341-2019",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "81775",
      "termination_date": "20200114",
      "more_code_info": "",
      "recall_initiation_date": "20181210",
      "postal_code": "76155-2633",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}